DRIO · DarioHealth Corp. Common Stock
View on chartInsiders & Stakes
| Zvi Ben-David Chief Financial Officer | ▲ Buy | Grant | 746,035 Shares held | 3/6/2024 | View profile |
| Erez Raphael Chief Executive Officer | ▲ Buy | Grant | 454,432 Shares held | 9/24/2026 | View profile |
| Cohen Oded GM MSK | ▼ Sell | Open Market | 430,764 Shares held | 10/14/2021 | View profile |
| Bacher Dror Chief Operating Officer | ▲ Buy | Grant | 265,926 Shares held | 5/18/2022 | View profile |
| Chen Franco-Yehuda Chief Financial Officer | ▲ Buy | Grant | 125,000 Shares held | 9/24/2026 | View profile |
| Jon H. Kaplan Director | ▲ Buy | Grant | 111,574 Shares held | 2/24/2025 | View profile |
| ANDERSON RICHARD ALAN President, GM of North America | ▼ Sell | Other | 108,877 Shares held | 6/9/2022 | View profile |
| Dennis M. McGrath Director | ▲ Buy | Grant | 88,737 Shares held | 9/24/2026 | View profile |
| Yoav Shaked Director | ▲ Buy | Grant | 87,582 Shares held | 9/24/2026 | View profile |
| Dennis Matheis Director | ▲ Buy | Grant | 87,026 Shares held | 9/24/2026 | View profile |
| John R. Palumbo Director | ▲ Buy | Grant | 66,500 Shares held | 9/24/2026 | View profile |
| Hila Karah Director | ▲ Buy | Grant | 58,965 Shares held | 9/24/2026 | View profile |
| Adam K. Stern Director | ▲ Buy | Grant | 57,717 Shares held | 9/24/2026 | View profile |
| Steven Charles Nelson Chief Commercial Officer | ▲ Buy | Grant | 34,750 Shares held | 9/11/2025 | View profile |
| Lawrence B. Leisure Director | ▲ Buy | Grant | 20,000 Shares held | 9/11/2025 | View profile |
Transaction History
| Dennis Matheis | ▲ Buy | Grant | 44,000 | $0 | 9/24/2026 |
| John R. Palumbo | ▲ Buy | Grant | 62,000 | $0 | 9/24/2026 |
| Adam K. Stern | ▲ Buy | Grant | 28,000 | $0 | 9/24/2026 |
| Dennis M. McGrath | ▲ Buy | Grant | 61,000 | $0 | 9/24/2026 |
| Yoav Shaked | ▲ Buy | Grant | 54,000 | $0 | 9/24/2026 |
| Chen Franco-Yehuda | ▲ Buy | Grant | 95,000 | $0 | 9/24/2026 |
| Hila Karah | ▲ Buy | Grant | 28,000 | $0 | 9/24/2026 |
| Erez Raphael | ▲ Buy | Grant | 297,000 | $0 | 9/24/2026 |
| Dennis Matheis | ▲ Buy | Open Market | 14,430 | $100K | 7/23/2026 |
| Adam K. Stern | ▼ Sell | Other | 11,760 | $475K | 9/18/2025 |
| Adam K. Stern | ▼ Sell | Other | 8,435 | $140K | 9/18/2025 |
| Steven Charles Nelson | ▲ Buy | Grant | 30,000 | $0 | 9/11/2025 |
| Adam K. Stern | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Lawrence B. Leisure | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Yoav Shaked | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Erez Raphael | ▲ Buy | Grant | 60,000 | $0 | 9/11/2025 |
| Chen Franco-Yehuda | ▲ Buy | Grant | 5,000 | $0 | 9/11/2025 |
| Dennis M. McGrath | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Hila Karah | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Dennis Matheis | ▲ Buy | Grant | 20,000 | $0 | 9/11/2025 |
| Steven Charles Nelson | ▲ Buy | Open Market | 40,000 | $21K | 8/27/2025 |
| Chen Franco-Yehuda | ▲ Buy | Grant | 500,000 | $0 | 5/15/2025 |
| Jon H. Kaplan | ▲ Buy | Grant | 30,000 | $0 | 2/24/2025 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 11/12/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $4K | 9/11/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $4K | 9/10/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $4K | 9/9/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $4K | 9/6/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $4K | 9/5/2024 |
| Erez Raphael | ▲ Buy | Open Market | 5,000 | $4K | 8/27/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 8/23/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 8/22/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 8/21/2024 |
| Erez Raphael | ▲ Buy | Open Market | 5,000 | $5K | 8/21/2024 |
| Erez Raphael | ▲ Buy | Open Market | 5,000 | $5K | 8/20/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 8/20/2024 |
| Steven Charles Nelson | ▲ Buy | Open Market | 5,000 | $5K | 8/19/2024 |
| Erez Raphael | ▲ Buy | Open Market | 5,000 | $5K | 8/19/2024 |
| Erez Raphael | ▲ Buy | Open Market | 2,000 | $2K | 8/16/2024 |
| Erez Raphael | ▲ Buy | Open Market | 3,000 | $3K | 8/16/2024 |
| Yoav Shaked | ▼ Sell | Other | 772 | $15K | 8/12/2024 |
| Erez Raphael | ▼ Sell | Other | 579 | $11K | 8/12/2024 |
| Dennis Matheis | ▼ Sell | Other | 965 | $18K | 8/12/2024 |
| Jon H. Kaplan | ▲ Buy | Grant | 70,000 | $0 | 3/6/2024 |
| Hila Karah | ▲ Buy | Grant | 70,000 | $0 | 3/6/2024 |
| Erez Raphael | ▲ Buy | Grant | 800,000 | $0 | 3/6/2024 |
| Dennis M. McGrath | ▲ Buy | Grant | 80,000 | $0 | 3/6/2024 |
| Dennis Matheis | ▲ Buy | Grant | 70,000 | $0 | 3/6/2024 |
| Adam K. Stern | ▲ Buy | Grant | 70,000 | $0 | 3/6/2024 |
| Zvi Ben-David | ▲ Buy | Grant | 400,000 | $0 | 3/6/2024 |
| Yoav Shaked | ▲ Buy | Grant | 90,000 | $0 | 3/6/2024 |
| Erez Raphael | ▼ Sell | Open Market | 1,200 | $7K | 1/13/2023 |
| Dennis M. McGrath | ▼ Sell | Open Market | 9,872 | $39K | 12/21/2022 |
| ANDERSON RICHARD ALAN | ▼ Sell | Other | 17,957 | — | 6/9/2022 |
| Yoav Shaked | ▲ Buy | Grant | 60,000 | $0 | 5/18/2022 |
| Zvi Ben-David | ▲ Buy | Grant | 95,000 | $0 | 5/18/2022 |
| Hila Karah | ▲ Buy | Grant | 80,000 | $0 | 5/18/2022 |
| Erez Raphael | ▲ Buy | Grant | 275,000 | $0 | 5/18/2022 |
| Bacher Dror | ▲ Buy | Grant | 95,000 | $0 | 5/18/2022 |
| Dennis M. McGrath | ▲ Buy | Grant | 55,000 | $0 | 5/18/2022 |
| Adam K. Stern | ▲ Buy | Grant | 55,000 | $0 | 5/18/2022 |
| Erez Raphael | ▼ Sell | Open Market | 800 | $15K | 11/8/2021 |
| Bacher Dror | ▼ Sell | Open Market | 804 | $15K | 11/8/2021 |
| Erez Raphael | ▼ Sell | Open Market | 200 | $4K | 11/5/2021 |
| Bacher Dror | ▼ Sell | Open Market | 200 | $4K | 11/5/2021 |
| Erez Raphael | ▼ Sell | Open Market | 7,857 | $145K | 11/4/2021 |
| Bacher Dror | ▼ Sell | Open Market | 200 | $4K | 11/4/2021 |
| Bacher Dror | ▼ Sell | Open Market | 8,016 | $153K | 11/3/2021 |
| Erez Raphael | ▼ Sell | Open Market | 30,483 | $578K | 11/3/2021 |
| Bacher Dror | ▼ Sell | Open Market | 4,363 | $83K | 11/2/2021 |
| Erez Raphael | ▼ Sell | Open Market | 41,279 | $770K | 11/2/2021 |
| Erez Raphael | ▼ Sell | Open Market | 25,804 | $465K | 11/1/2021 |
| Cohen Oded | ▼ Sell | Open Market | 20,000 | $322K | 10/14/2021 |
| Erez Raphael | ▲ Buy | Grant | 695 | $0 | 10/10/2021 |
| Bacher Dror | ▲ Buy | Grant | 357 | $0 | 10/10/2021 |
| Zvi Ben-David | ▲ Buy | Grant | 369 | $0 | 10/10/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
DarioHealth's Aon Analysis Confirms 2.5%-7.2% Cost Reduction
DarioHealth released an independent Aon analysis that backs its estimate of a 2.5%–7.2% reduction in in‑year healthcare costs. The study adds credibility to the company’s cost‑efficiency claims and may influence how analysts view its valuation. The stock is trading near its $7.38 support level, within the 52‑week range of $5.84–$17.74. The analysis could affect investor sentiment as the company continues to pursue its growth strategy.
DarioHealth's Aon Analysis Confirms 2.5%-7.2% Cost Reduction. DarioHealth released an independent Aon analysis that backs its estimate of a 2.5%–7.2% reduction in in‑year healthcare costs. The study adds credibility to the company’s cost‑efficiency claims and may influence how analysts view its valuation. The stock is trading near its $7.38 support level, within the 52‑week range of $5.84–$17.74. The analysis could affect investor sentiment as the company continues to pursue its growth strategy.